| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.00066 | 1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.00065 | 1 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.00053 | 1 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.00053 | 1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00044 | 1 |